April 18, 2018 The Department of Clinical Neurological Sciences hosted its 2018 Departmental Research Day on April 17th, 2018. This annual event features platform and poster presentations by residents, graduate students, PhD candidates, and postdoctoral fellows.
April 02, 2018 MS is an inflammatory disease in which the body's immune system attacks its own tissues. With MS, the immune system destroys myelin, which is the fatty substance that coats and protects nerve fibers in the brain and spinal cord.
March 27, 2018 On March 27th, 2018, 36 years after the Western University Epilepsy Program was originally founded, the Department of Clinical Neurological Sciences honored its co-founders, Dr. Warren T. Blume and Dr. John P. Girvin, with a plaque to be placed outside of what has become Canada’s largest Epilepsy Monitoring Unit (EMU).
March 13, 2018 The Department of Clinical Neurological Sciences will host its annual Research Day on April 17th, 2018 at the Ivey Spencer Leadership Centre. The full day event will feature research presentations from faculty, residents, graduate students and postdoctoral fellows as well as a guest presentation from Dr. Tom Mikkelsen.
February 01, 2018 On January 31st, 2018, the Department of Clinical Neurological Sciences at the Schulich School of Medicine & Dentistry at Western University celebrated the Charles G. Drake Distinguished Visiting Professorship.
January 15, 2018 Researchers at Western University have uncovered a unique neurobiological pathway triggered by head trauma which underlies both Chronic Traumatic Encephalopathy (CTE) and amyotrophic lateral sclerosis (also called ALS or Lou Gehrig’s Disease).
November 21, 2017 Thanks to two successful surgeries performed by Dr. Drake she was able to make a full recovery. She continued her singing and acting career and starred in the inspirational drama series Touched By An Angel, still in syndication.
November 09, 2017 Dr. Matthew O. Hebb, a Lawson scientist, neurosurgeon at London Health Sciences Centre (LHSC) and assistant professor of neurosurgery at Western University's Schulich School of Medicine & Dentistry, was recognized for the development of two innovations that offer hope in treating two deadly diseases – Parkinson’s disease and glioblastoma.
November 02, 2017 In October 2017, two Clinical Neurological Sciences (CNS) Department members, Dr. Michael Nicolle, Chief of Neurology and Dr. David Steven, Co-Chair of the Epilepsy Program, traveled to Kuwait with a delegation from the Royal College of Physicians and Surgeons of Canada (RCPSC) to assist the Kuwait Institute for Medical Specializations (KIMS) administer specialty training exams to their neurology and neurosurgery residents, the first time that this type of examination has been administered in Kuwait.
October 29, 2017 “EVT is a remarkable treatment option for stroke patients who won’t see a lot of benefit from tPA because of the size or placement of the clot,” says Dr. Mel Boulton, neurosurgeon at LHSC. “It’s not only a procedure that saves lives, it has also been demonstrated to lead to better patient outcomes; so that someone who would be destined to have deficits without EVT can be returned to normal or near normal quality of life.”
October 03, 2017 Dr. Vladimir Hachinski is among a group of exceptional healthcare leaders who will be inducted into The Canadian Medical Hall of Fame (CMHF). Dr. Hachinski, a Distinguished University Professor in Clinical Neurological Sciences, is a world-renowned neurologist and has transformed the understanding, diagnosis, treatment and prevention of the two greatest threats to the brain, stroke and dementia.
September 28, 2017 In his last year of the Neurosurgical Residency program at Schulich Medicine & Dentistry, Dr. Faizal Haji says the great mentors he has encountered over the years, and at all levels of education, have helped him to realize his potential and accomplish new feats.
September 26, 2017 Tuesday, September 26th was “Awards Day” in the Department of Clinical Neurological Sciences. Every fall, the Department honours residents and faculty members for their accomplishments over the previous year.
September 22, 2017 “Cognition is often described as an invisible symptom in multiple sclerosis (MS),” explained Dr. Sarah Morrow. “It’s easy to write off because there isn’t a predictable decline like we see in dementia; it’s more episodic. It also presents differently from dementia – the first signs people notice are usually difficulty processing information or not remembering things unless they are written down.”
September 21, 2017 Dr. Shannon Venance, neurologist at LHSC, along with Dr. Anita Florendo-Cumbermack and nurse practitioner, Wilma Koopman, lead the adult care team for muscular dystrophy within the neuromuscular clinic.
September 21, 2017 Functional MRI showed widespread recovery in both hemispheres of Humphrey’s brain, said Spence, who is also a scientist at Western’s Robarts Research Institute. Swimming had apparently triggered a rewiring within parts of the brain.
July 03, 2017 Researchers from the Schulich School of Medicine & Dentistry are part of a groundbreaking study showing that a common acne medication called minocycline can be used to help treat multiple sclerosis (MS) in its earliest stages.
June 14, 2017 London Health Sciences Centre’s (LHSC) Epilepsy Program is the first in Ontario to perform a robotic-assisted stereoelectroencephalography (SEEG) procedure, in which electrodes are placed into the brain to map epileptic seizure activity.
April 01, 2017 In June 2016, LHSC University Hospital neurosurgeon Dr. Keith MacDougall and his team performed an eight-hour surgery to implant two electrodes deep into DJ’s brain. The electrodes are connected to a battery-powered neurostimulator which is embedded under the skin just below her collarbone.
November 22, 2016 Adrian Budhram has a knack for the quick diagnosis. The third-year Neurology resident is a three-time winner of the Think Like a Doctor monthly feature in the New York Times. He has won back-to-back months, prompting long-time columnist Dr. Lisa Sanders to joke she may have to initiate a ‘let others play’ rule when it comes to Budhram.
August 01, 2016 “Pilocytic astrocytoma is a benign tumour located at the back of the head in the cerebellum, occurring commonly in children under 20 years of age,” says Dr. Ranger. “They are often curable with surgery if located in an accessible part of the brain.”
August 01, 2016 “Fast action is vital in patients presenting with stroke symptoms to determine whether they have a clot obstructing blood flow or a hemorrhage in the brain,” says Dr. Mandzia. “This allows us to determine which treatment options are available to potentially limit the amount of damage that could have a severe impact on quality of life.”
June 10, 2016 Dr. Steve Lownie is a neurosurgeon and neurointerventionalist, with a primary interest in vascular diseases of the brain. He was honoured with the 2016 Lawson Innovation Award for his recent publication titled, “Catheter Based Selective Hypothermia Reduces Stroke Volume during Focal Cerebral Ischemia in Swine,” published in the Journal of NeuroInterventional Surgery.
October 06, 2015 Lawson Health Research Institute hosted the second annual Lawson Impact Awards on May 21, 2015 celebrating
hospital-based scientists, staff, trainees and partners who are making an impact in London, and around the world.
300 guests attended the event, including Howard Rundle, Lawson Board Chair, Matt Brown, Mayor of London, and
senior leaders from LHSC, St. Joseph’s, and Western University
October 04, 2015 If you happened to be around LHSC’s University Hospital on March 26, you might have seen a lot of people wearing purple, and it was no coincidence. It was Purple Day for epilepsy awareness
October 01, 2015 Intrigued by the potential of this technology to measure and assess movement, LHSC’s Dr. Mandar Jog, neurologist, and engineer Dr. Rajni Patel – both also researchers with Lawson Health Research Institute – are testing how the suits can be used to improve the lives of patients with Parkinson’s by helping physicians understand how well a medical intervention is working to ease symptoms.
October 01, 2015 “There is unfortunately no specific test for ALS. As a consequence, when symptoms begin they can be quite mild and may be initially dismissed by the patient, or even the family doctor. When the symptoms evolve to be more noticeable, the initial symptoms may not be specific for ALS and several potential diagnoses need to be considered,” says neurologist Dr. Christen Shoesmith, Medical Director of the MND clinic.